HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cascade Hydrogenation-Cyclization of Levulinic Acid into γ-Valerolactone Catalyzed by Half-Sandwich Iridium Complexes: A Mechanistic Insight from Density Functional Theory.

Abstract
DFT calculations have been performed to illuminate the mechanism of cascade hydrogenation-cyclization of levulinic acid (LA) into γ-valerolactone (GVL) catalyzed by half-sandwich iridium complexes. It is shown that the favorable mechanism involves a heterolytic hydrogen cleavage for Ir-OH species to form a monohydride iridium species, concerted reduction of the C═O unit of LA, hydrogen migration and dehydration to produce the iridium alkoxo complex, and cyclization of the iridium alkoxo complex to generate GVL. The presence of water and counterions are proposed to be important for the hydrogenation where the former works as a hydrogen donor and the latter acts as a hydrogen shuttle. Intriguingly, the cyclization process exploits a metal- and counterion-assisted concerted dehydration-cyclization mechanism different from the known ones that feature the intramolecular esterification of 4-hydroxyvaleric acid. The effectiveness of the half-sandwich iridium complex with the double-methoxy group on the bipyridine ligand-catalyzed system is attributed to the stronger electron-donating methoxy group, which is beneficial to increase the electron density at the Ir center and hence promote the Ir-H bond cleavage. In addition, the calculated free energy barrier for the cascade hydrogenation-cyclization catalyzed by the iridium complex with a dipyridylamine ligand is comparable with that promoted by the iridium complex with the double-methoxy group on the bipyridine ligand (24.8 vs 26.8 kcal/mol). The present work rationalizes the experimental findings and provides in-depth insights into the catalysis of the half-sandwich iridium complexes.
AuthorsJingjing Li, Yuan Yang, Huimin Di, Jinzhao Wang
JournalThe Journal of organic chemistry (J Org Chem) Vol. 86 Issue 1 Pg. 674-682 (01 01 2021) ISSN: 1520-6904 [Electronic] United States
PMID33274933 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: